NCT02963324View on ClinicalTrials.gov

Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Malaria
Interventions
DRUG

Ivermectin

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT02963324 - Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers | Biotech Hunter | Biotech Hunter